Sunovion Cns Development Canada Ulc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/16 Q2

ended 03/31/16 Q1

ended 12/31/15 FY 2015 – amended

ended 12/31/15 FY 2015

ended 09/30/15 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Registration of securities for employees

Supplemental info

Ownership Filter

Visium Asset Management, LP

Aisling Capital III LP

Orbimed Advisors LLC

Sunovion Pharmaceuticals Inc.

Franklin Resources Inc.

News Filter

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Pharmaceuticals Completes Acquisition of Cynapsus Therapeutics

Cynapsus Therapeutics Obtains Final Court Order and HSR Waiting Period Expires for Plan of Arrangement With Sunovion Pharmaceuticals

Cynapsus Therapeutics Securityholders Approve the Plan of Arrangement With Sunovion Pharmaceuticals

Unregistered Sales of Equity Securities

Proxies

No filings in this category.

Other Filter

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order

Notice of effectiveness